Interleukin-13 (IL-13) was associated with deteriorating spirometric data, but the study's novelty lies in the potential identification of new anti-IL-13 drugs in the treatment of RA-ILD, given its relation to pathogenesis [36]. The gene discussed is IL13; the disease is rheumatoid arthritis.